Latest Headlines
-
Brainscan: The First Alzheimer's Blood Test For Consumers Is Now Available
7/17/2024
Apollo Health, the leading provider of innovative health solutions for cognition announces BrainScan through Neurocode, a clinical laboratory that offers cutting edge diagnostic tests and biomarkers.
-
Danaher Announces Two New Centers Of Innovation In Diagnostics To Transform Precision Medicine Development
7/17/2024
Danaher Corporation (NYSE: DHR) ("Danaher"), a global science and technology innovator, announced the launch of two new Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP)-certified labs intended to accelerate the development of Companion Diagnostics (CDx) and Complementary Diagnostics (CoDx).
-
Sapio Sciences Launches Partner Program To Accelerate Research And Diagnostics
7/16/2024
Sapio Sciences, the science-aware lab informatics platform, today announced the Sapio Sciences Partner Program.
-
Tempus Expands Immuno-Oncology Portfolio With Launch Of AI-Enabled, Multimodal Immune Profile Algorithmic Tests
7/16/2024
Tempus AI, Inc., a leader in artificial intelligence and precision medicine, today announced that its multimodal immune profile score (IPS) algorithmic test is now available for research use only (RUO).
-
Dallas Morning News Features Cancer Check Labs' Innovative Early Cancer Detection Blood Test
7/16/2024
Cancer Check Labs, a leader in early cancer detection, has been spotlighted in a recent Dallas Morning News article for its groundbreaking blood test that detects over 200 types of cancer with unprecedented accuracy.
-
DPX Technologies Announces Additional Automation Compatibility For Their Flagship Dispersive Pipette Xtraction Technology
7/15/2024
DPX Technologies, a biotechnology company providing solutions for automated sample preparation, today announces additional XTR tip format compatibility allowing dispersive pipette extraction methods to be automated with the most common liquid handlers.
-
DNA Labs International Acquires Intermountain Forensics Laboratory Operations, Boosts Capabilities With WGS Technology
7/15/2024
DNA Labs International (DLI), a leading privately owned accredited forensic DNA laboratory, is thrilled to announce the finalized acquisition of the laboratory operations of Intermountain Forensics (IMF), a non-profit DNA laboratory renowned for its commitment to high-quality forensic services.
-
Children's Hospital Of Richmond At VCU Opens Region's First Pediatric Cardiac Catheterization And Electrophysiology Lab
7/12/2024
A cardiac catheterization and electrophysiology lab is now open in the Children’s Tower. The new lab is the first dedicated cardiac procedure suite of its kind in the region, allowing for minimally invasive testing and procedures in a pediatric-specific environment.
-
MGI Tech And Predica Diagnostics Team Up For Precision RNA Sequencing In Oncology
7/11/2024
MGI (MGI Tech Co., Ltd. or its subsidiaries, together referred to MGI), a company committed to building core tools and technologies that drive innovation in life science, today announced the collaboration with Predica Diagnostics, a leading innovator in oncology diagnostics, to develop Predica's targeted RNA sequencing tests on the cost-effective MGI Next-generation sequencing platforms.
-
Thermo Fisher Scientific To Help Advance Myeloid Cancer Clinical Research And Treatment Utilizing Next Generation Sequencing Technology
7/11/2024
To help accelerate research into new treatments for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS), Thermo Fisher Scientific Inc., the world leader in serving science, is partnering with the National Cancer Institute (NCI) – part of the National Institutes of Health – on the myeloMATCH (Molecular Analysis for Therapy Choice) precision medicine umbrella trial.